Please Wait
Applying Filters...
menu
    • menu
    CDMO Activity Tracker: Lupin’s CDMO commissions oncology block in India; Cambrex, Axplora, Hovione expand operations

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    Polmacoxib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 19,571Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    29/11/2025 Hwail Pharm Co., Ltd
    South Korea
    		 Hwail Pharmaceutical Co., Ltd. 2014-7-ND Polmacoxib 2017-04-03 Hwail Pharmaceutical Co., Ltd. @ IT Chem Co., Ltd. South Korea 57, Jagyeokongdan 3-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do @ 231, Yangcheongsongdae-gil, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do
    29/11/2025 Kyongbo Pharmaceutical Co., Ltd
    South Korea
    		 CG Invites Co., Ltd. 6-1-ND Polmacoxib 2015-02-05 Kyungbo Pharmaceutical Co., Ltd. South Korea 174 Silok-ro, Asan-si, Chungcheongnam-do
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.